We are a premier technology company that is developing a cell specific payload delivery solution with applications from monogenic diseases to oncology, neurodegenerative disease, metabolic disease and more.
Connect With UsCARGO is Carrigent’s patent-pending technology that offers increased loading capacity, cell-specific targeting and reduced systemic toxicity.
See Our ApproachCarrigent's aim is to solve limitations associated with delivery platforms with the CARGO system. We can reduce cost, toxicity and immunogenicity issues while providing a broader array of payload and an increased capacity. CARGO is the next generation advanced therapy delivery platform.
Get to Know Us